FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:931-933 March 21, 2002 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Moss, A. J. PubMed Citation

Almost 250,000 out-of-hospital cardiac arrests occur annually in the United States; the majority are attributed to coronary artery disease. About half of these episodes appear to be caused by ventricular tachyarrhythmias in the absence of acute myocardial infarction. With occasional exceptions, secondary prevention in the form of implantable cardiac defibrillators is chosen for survivors of cardiac arrest. More than 95 percent of victims of out-of-hospital cardiac arrest die during the episode, but the few who are quickly resuscitated usually live many additional years if they receive a defibrillator. The extremely low survival rate after out-of-hospital cardiac arrest is the motivating . . . [Full Text of this Article]

References

Related Letters:

Implantable Cardiac Defibrillators
Donaldson R. M. Jr., Stecker E. C., Pollack H. A., Carbajal E. V., Smith R. G., Cohen S. E., Gollapudi A. K., Spivack C., Moss A. J., Hall W. J., Zareba W.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:365-367, Aug 1, 2002. Correspondence

This article has been cited by other articles:

• Cantillon, D. J., Stein, K. M., Markowitz, S. M., Mittal, S., Shah, B. K., Morin, D. P., Zacks, E. S., Janik, M., Ageno, S., Mauer, A. C., Lerman, B. B., Iwai, S. (2007). Predictive Value of Microvolt T-Wave Alternans in Patients With Left Ventricular Dysfunction. J Am Coll Cardiol 50: 166-173 [Abstract] [Full Text]  
• Bailey, J. J., Hodges, M., Church, T. R. (2007). Decision to Implant a Cardioverter Defibrillator after Myocardial Infarction: The Role of Ejection Fraction v. Other Risk Factor Markers. Med Decis Making 27: 151-160 [Abstract]  
• Kaufman, E. S., Bloomfield, D. M., Steinman, R. C., Namerow, P. B., Costantini, O., Cohen, R. J., Bigger, J. T. Jr (2006). "Indeterminate" Microvolt T-Wave Alternans Tests Predict High Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction. J Am Coll Cardiol 48: 1399-1404 [Abstract] [Full Text]  
• Goldberger, Z., Lampert, R. (2006). Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies. JAMA 295: 809-818 [Abstract] [Full Text]  
• Bloomfield, D. M., Bigger, J. T., Steinman, R. C., Namerow, P. B., Parides, M. K., Curtis, A. B., Kaufman, E. S., Davidenko, J. M., Shinn, T. S., Fontaine, J. M. (2006). Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction. J Am Coll Cardiol 47: 456-463 [Abstract] [Full Text]  
• Bloomfield, D. M., Steinman, R. C., Namerow, P. B., Parides, M., Davidenko, J., Kaufman, E. S., Shinn, T., Curtis, A., Fontaine, J., Holmes, D., Russo, A., Tang, C., Bigger, J. T. Jr (2004). Microvolt T-Wave Alternans Distinguishes Between Patients Likely and Patients Not Likely to Benefit From Implanted Cardiac Defibrillator Therapy: A Solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Conundrum. Circulation 110: 1885-1889 [Abstract] [Full Text]  
• Boriani, G., Biffi, M., Martignani, C., Camanini, C., Grigioni, F., Rapezzi, C., Branzi, A. (2003). Cardioverter-defibrillators after MADIT-II: the balance between weight of evidence and treatment costs. Eur J Heart Fail 5: 419-425 [Abstract] [Full Text]  
• Saumarez, R. C., Chojnowska, L., Derksen, R., Pytkowski, M., Sterlinski, M., Huang, C. L.-H., Sadoul, N., Hauer, R. N.W., Ruzyllo, W., Grace, A. A. (2003). Sudden Death in Noncoronary Heart Disease Is Associated With Delayed Paced Ventricular Activation. Circulation 107: 2595-2600 [Abstract] [Full Text]  
• Ezekowitz, J. A., Armstrong, P. W., McAlister, F. A. (2003). Implantable Cardioverter Defibrillators in Primary and Secondary Prevention: A Systematic Review of Randomized, Controlled Trials. ANN INTERN MED 138: 445-452 [Abstract] [Full Text]  
• van Veldhuisen, D. J., van Gilst, W. H. (2003). The pharmacological management of heart failure: too many treatments?. Eur J Heart Fail 5: 5-8 [Full Text]  
• (2003). ICDS BENEFICIAL IN A MORE EASILY IDENTIFIABLE POPULATION. Journal Watch Cardiology 2003: 7-7 [Full Text]  
• Donaldson, R. M. Jr., Stecker, E. C., Pollack, H. A., Carbajal, E. V., Smith, R. G., Cohen, S. E., Gollapudi, A. K., Spivack, C., Moss, A. J., Hall, W. J., Zareba, W. (2002). Implantable Cardiac Defibrillators. NEJM 347: 365-367 [Full Text]  
• Silfvast, T., Pettila, V., Ballew, K. A., Philbrick, J. T., Tomkiewicz, W., Meininghaus, D. G., Langes, K., Spehn, J., Dorian, P., Schwartz, B., Cooper, R. (2002). Amiodarone versus Lidocaine for Shock-Resistant Ventricular Fibrillation. NEJM 347: 368-370 [Full Text]  
• Coletta, A., Thackray, S., Nikitin, N., Cleland, J. G.F. (2002). Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL. Eur J Heart Fail 4: 381-388 [Abstract] [Full Text]  
• (2002). ICDs Beneficial in a More Easily Identifiable Population. Journal Watch Cardiology 2002: 1-1 [Full Text]